Trinity White Paper
5th Annual Trinity Next Gen Launch Report
2025 Launch Paradox: Ambiguity, Overperformance, and What Standouts from the Class of 2025 Teach Us About Launch Excellence in Uncertain Markets
Authors
What 2025 launches teach about performance
This report assesses 36 U.S. pharma and biotech launches from 2025. Policy uncertainty, volatile capital markets, and fewer first-in-class approvals shaped the 2025 launch environment. Yet 51% of launches outperformed Wall Street consensus revenue expectations. That compares with a 39% historical four-year average.
Through case studies of Brinsupri®, Tryngolza®, and Attruby®, the report examines how selected companies created demand by pre-launch market shaping and reduced access barriers to perform amid uncertainty.
Use this white paper if you are
Planning a U.S. pharma or biotech launch and are interested in how uncertain policy or capital-market environment will affect you
Eager to understand how best to enable operational excellence and accelerate uptake (while retaining strong customer experience) from pre-launch market shaping to post-launch pull-through
Shaping or building the market through patient identification and/or creative field team execution
Entering a crowded market with limited clinical separation
About this white paper
This is Trinity’s 5th annual Next Gen Launch Report.
The report also shows where these approaches have limits. In crowded markets with limited clinical separation, execution alone may not create rapid uptake.
What you will learn
How selected companies establish clear and meaningful differentiation, followed by heavy investment in market expansion
How they build the market through patient identification and field team execution
How they accelerate time to access through guideline inclusion, pricing strategy, and tailored patient-support services
How to use the data and case study lessons to inform your next launch
Read Now
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.